Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Monday Poster Session Category: Small Intestine P4045 - Comparative Risk of Small Intestinal Bacterial Overgrowth (SIBO) Among Patients Using GLP-1 Receptor Agonists: A Real-World Analysis Using TriNetX Monday, October 27, 2025 10:30 AM - 4:00 PM PDT Location: Exhibit Hall Has Audio Presenting Author(s) Lina AlQirem, MD 1 , Suria Devarapalli, DO 1 , Adalberto Guzman, MD 2 , Murad Qirem, MD 3 , Meer A
Inhibitory control test for the diagnosis of minimal hepatic encephalopathy
Microdoses maintain metabolic benefits while minimizing nausea and GI upset that cause many patients to quit therapy
If the material doesnt cool or dissipate that heat, it will stay right at the surface, making it uncomfortable to sleep
Physiol behavior
Should I tell my pediatrician I am taking GLP-1 medication
US$ 20.42
US$ 21.68
:max_bytes(150000):strip_icc()/VWH-GettyImages-2275860768-a6f6e63304e048d0a829844c1dacbd8d.jpg)
US$ 27.33
